English
This article is from Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India , volume 27 . Abstract Context:: Radiolabelled metaiodobenzylguanidine (MIBG) is commonly used for imaging of neuroendocrine tumors (NETs). The hybrid imaging with single photon emission computerized tomography/computerized tomography (SPECT/CT) co-registration can give that additional edge to this functional imaging modality. Aims:: To study the additional value of 131I-MIBG SPECT/CT scintigraphy in evaluation of NETs. Settings and Design:: We performed a retrospective study of the scintigraphic data of patients referred to our department for detection and follow-up of NETs from 2004 to 2008. Materials and Methods:: Total number of studies were 370. Twenty-eight patients with equivocal findings on planar imaging had undergone additional SPECT/CT imaging. The contribution made by SPECT/CT imaging in these studies was analyzed. Results:: In 27 of 28 cases, SPECT/CT provided vital additional information. Conclusions:: We concluded that SPECT/CT co-registration helps in exclusion, identification, and localization of primary and metastatic NETs. It differentia
Sign in with your free account to read, download EPUBs or listen.
Ebook · Iodine-131MIBG SPECT/CT in neuroendocrine tumours: An institutional experience. · Verma, Priyanka, Chanadana,, Hephzibah, Julie, Shanthly, Nylla, Oommen, Regi · Internet Archive